0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

How The BioMarin (BMRN) Story Is Shifting With Voxzogo Risks And The Amicus Deal [Yahoo! Finance]

BioMarin Pharmaceutical Inc. (BMRN)  More Company Research Source: Yahoo! Finance
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
Price targets on BioMarin Pharmaceutical now span the mid US$50s to just above US$100, reflecting a wide reset in expectations across Wall Street. Analysts anchor their views in different readings of Voxzogo's long term potential, the planned Amicus acquisition, and how much credit to give the broader rare disease portfolio and pipeline. As you read on, you will see what is driving these shifts and how to keep track of an analyst narrative that is still very much in motion. Stay updated as the Fair Value for BioMarin Pharmaceutical shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on BioMarin Pharmaceutical. What Wall Street Has Been Saying ?? Bullish Takeaways Several firms, including Barclays, Canaccord, Bernstein, Oppenheimer and BofA, have set targets in the US$90 to US$105 range. They cite optimism around the rare disease portfolio and pipeline, the planned Amicus deal and Voxzogo label expansion opport [Read more]
IMPACT SNAPSHOT EVENT TIME: BMRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
BMRN alerts
from News Quantified
BMRN
NEWS
BMRN
Earnings
BMRN
Analyst Actions
BMRN
SEC Filings
Stockreport

How The BioMarin (BMRN) Story Is Shifting With Voxzogo Risks And The Amicus Deal [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
More Company Research Source: Yahoo! Finance
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
Price targets on BioMarin Pharmaceutical now span the mid US$50s to just above US$100, reflecting a wide reset in expectations across Wall Street. Analysts anchor their views in different readings of Voxzogo's long term potential, the planned Amicus acquisition, and how much credit to give the broader rare disease portfolio and pipeline. As you read on, you will see what is driving these shifts and how to keep track of an analyst narrative that is still very much in motion. Stay updated as the Fair Value for BioMarin Pharmaceutical shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on BioMarin Pharmaceutical. What Wall Street Has Been Saying ?? Bullish Takeaways Several firms, including Barclays, Canaccord, Bernstein, Oppenheimer and BofA, have set targets in the US$90 to US$105 range. They cite optimism around the rare disease portfolio and pipeline, the planned Amicus deal and Voxzogo label expansion opport [Read more]
IMPACT SNAPSHOT
EVENT TIME:
BMRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS